Interim President Michael Bernstein with Fotis Sotiropoulos and Peter Tonge
Ingenuity, innovation and cross-campus collaboration have been keeping patients more comfortable, care providers better protected and saving lives as we enter the third month of the COVID battle at Stony Brook University. In this episode of “Beyond the Expected: The Coronavirus Effect,” Interim President Michael Bernstein talks with two experts from Stony Brook University whose areas have been driving results through engineering-driven medicine, which is in partnership with Stony Brook Medicine. They have been redesigning ventilators, improving respirators and making hand sanitizer, all at the rapid pace pandemic conditions have necessitated.
To give you an idea of the magnitude of the effort, 9,000 faculty and staff have helped care for 5,000 symptomatic patients who have come through our doors since we saw the first COVID-suspected patient back in February.
- Fotis Sotiropoulos, Dean of the College of Engineering and Applied Sciences at Stony Brook University and a SUNY Distinguished Professor of Civil Engineering. Since joining the faculty in October 2015, Dean Sotiropoulos has steered the College toward tackling major societal grand challenges by advancing convergence science initiatives in collaboration with the School of Medicine, the School of Marine and Atmospheric Sciences, the College of Arts and Sciences and Brookhaven National Laboratory. He is driving University-wide initiatives in Engineering-Driven Medicine and Artificial Intelligence and is at the forefront of the College’s strategic commitment to expand diversity and invent the future of engineering education in the era of exponential technologies.
- Peter Tonge, Chair of the Department of Chemistry and a SUNY Distinguished Professor of Chemistry and Radiology at Stony Brook University. Dr. Tonge is a founding member of the Institute of Chemical-Biology and Drug Discovery and co-Directs the NIH-funded chemical biology training program. He is also Director of the Center for Advanced Study of Drug Action, whose mission is to improve the prediction of drug activity in humans, thereby increasing the success rate of new drug approvals. He will speak about the research and solutions the Department of Chemistry has been offering to help deal with the pandemic crisis.
This episode originally aired on Facebook Live on Wednesday, May 6, 2020.